Search results for " market" in Articles / App Notes
Article
A Plastic Pipeline for Commercial Bioprocessing?
Pressure to get drugs to market faster, the smaller batch sizes characteristic of targeted therapies, and the comfort level biopharma companies and contract manufacturing organizations (CMOs) have wit…
Article
Industry Adoption of Single-Use Systems Remains Low
The market for single-use technology is growing, however, as capacity needs evolve.
Conservative attitude
Conservative attitudes tend to dominate the pharmaceutical and biop…
Article
Process Development: What May Lie Ahead in 2018?
Markets and Markets recently projected single-use bioreactors will be a $1.09-billion market by 2021 (up from $408.4 million in 2016), according to the same article.
In 2017, Process Development F…
Article
Patenting Prospects for Cell-Based Therapies
Indeed, it may be the case that regulatory exclusivity—analogous to the 12-year market exclusivities for biologic drugs provided by the Biologics Price Competition and Innovation Act (BPCIA)—will be m…
Article
Cost Considerations Drive Lean Technology in Biopharmaceutical Manufacturing
Therefore, a biophysical potency measurement plays a much bigger role in the biosimilar market as opposed to [the market for] the original molecule.”
Daniel Galebraith, who is chief scientific off…
Article
A Q&A on Bioprocessing Trends and Technologies at INTERPHEX 2016
Similar to the single-use system advances, continuous manufacturing for the production of biologics is showing some step-by-step advances, but still trails advances on the small-molecule market.
I…
Article
Designing a Biomanufacturing Facility Incorporating Single-Use Technologies
Alternatively, it should be possible to consider what quantity (in kilograms) of the bulk API needs to be produced for each product within the facility per year to meet clinical trial or commercial ma…
Article
mAbs to Watch in 2016
And there may be many more of these types of proteins on the horizon—as many as 14 are projected to hit the market in 2016, according to data compiled by EvaluatePharma, in collaboration with BioPharm…
Article
GMP Challenges for Advanced Therapy Medicinal Products
In fact, these difficulties could be a prime reason why, up until 2014, only four medicines under the ATMP regulation had been given marketing authorization in the EU’s centralized medicines licensing…
Article
Breakthrough Drugs Raise Development and Production Challenges
Nearly 15 important new therapies have come to market more quickly as a result, contributing to the recent rise in new drug approvals. FDA acting commissioner Stephen Ostroff pointed out at the annual…